Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 2
Encontrada(s) 1 página(s)

e_Buah Biblioteca Digital Universidad de Alcalá
Publication Artículo científico (JournalArticle)

Cytotoxic effects of water-soluble N-heterocyclic carbene platinum(II) complexes on prostatic tumor PC3 and leukemia NB4 human cells

  • Díez Ballesteros, José Carlos|||0000-0002-6435-505X
  • Baquero Velasco, Edwin Arley
  • Rubio Serrano, Virginia
  • Flores Serrano, Juan Carlos|||0000-0001-6356-555X
  • Herráez Sánchez, Ángel|||0000-0002-9900-6845
  • Tejedor Gilmartín, María Cristina
  • De Jesús Alcañiz, Ernesto|||0000-0001-8101-1358
  • García Pérez, Ana Isabel
17 p., The purpose of this work was to study water-soluble platinum complexes as potential therapeutic agents. We used water-soluble platinum(II) complexes containing sulfonated N-heterocyclic carbene ligands (NHC), applied on two human cell models: human NB4 acute promyelocytic leukemia and PC3 prostatic cancer cells. We studied the toxic effects on these two types of human tumor cells. We analyzed metabolic activity, membrane damage, cell cycle, DNA fragmentation and programmed cell death. In human NB4 leukemia cells, the water-soluble dimethyl NHC complex 5Me proved highly toxic. It extinguished cell metabolism at 1 mM for 24 h. This treatment gave rise to the presence of fragmented DNA (subdiploid DNA). This compound promoted programed cell death in 60% of the cells. At longer times, the treatments produced neither higher fragmentation of DNA nor augmented apoptosis. 5Me complex, at 100 µM, showed slight toxicity on NB4 cells. In PC3 cells, dimethyl complex 5Me (1 mM for 24 h) is less toxic (reduced DNA fragmentation and programmed cell death) than in NB4 cells. Mono-NHC complexes 4 and 5 treatments at a high concentration for 24 h on PC3 cells produced apoptosis (30% of the cells) but their damage on cell permeability and DNA fragmentation was weak. Thus, PC3 cells are more resistant to NHC platinum(II) complexes than NB4 cells., Instituto de Salud Carlos III, Universidad de Alcalá, Comunidad Autónoma de Madrid, Ministerio de Ciencia e Innovación
e_Buah Biblioteca Digital Universidad de Alcalá
Publication Artículo científico (JournalArticle)

Cytotoxicity of esculetin compared with vinblastine and paclitaxel in PC-3 prostate cancer cells

  • García Pérez, Ana Isabel
  • Rubio Serrano, Virginia
  • Herráez Sánchez, Ángel|||0000-0002-9900-6845
  • Puebla Jiménez, Lilian|||0000-0002-0681-3235
  • Díez Ballesteros, José Carlos|||0000-0002-6435-505X
14 p., Objectives: Metastatic prostate cancer is among the therapy-resistant human neoplasms. PC-3 is a commonly used experimental cell line that does not express androgen receptors. We compared the cytotoxicity of esculetin with that of vinblastine and paclitaxel on prostatic tumour PC-3 cells. Methods: Cells were treated with either esculetin (100 or 250 mu M), vinblastine (50 mu M) or paclitaxel (100 or 200 mu M) for 19 to 72 h. Cells were assessed for metabolic viability, membrane integrity, DNA fragmentation and cell cycle analysis. Apoptosis was checked with annexin and propidium iodide. Results: Esculetin decreased the metabolic activity of PC-3 cells in a time- and concentration-dependent way. The metabolic activity of vinblastine- and paclitaxel-treated cells did not show time-dependence. Cells treated with 250 mu M esculetin for 48 or 72 h showed apoptosis levels similar to those produced by 50 mu M vinblastine at these incubation times or by 200 mu M paclitaxel at 19 h. Vinblastine and paclitaxel produced cell cycle arrest in the G2/M phase after incubation for 19 h. In contrast, esculetin did not significantly affect the cell cycle. Conclusions: A differential action of esculetin on PC-3 prostate cells may be inferred. This may be relevant for novel therapies against resistant prostate cancer., Instituto de Salud Carlos III, Universidad de Alcalá